RhumbLine Advisers’s Dova Pharmaceuticals DOVA Stock Holding History
Bought
Maintained
Sold
RhumbLine Advisers's DOVA Position: Q4 2019 in Review
RhumbLine Advisers sold out of Dova Pharmaceuticals (DOVA) in Q4 2019, closing a stake of 12,827 shares — an estimated $359K sold.
RhumbLine Advisers first reported a position in DOVA in Q2 2018 and held it in 6 quarters. The position peaked at $359K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.
- RhumbLine Advisers reported no remaining Dova Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
- RhumbLine Advisers sold 12,827 Dova Pharmaceuticals shares in Q4 2019, an estimated $359K.
- RhumbLine Advisers first reported a position in Dova Pharmaceuticals in Q2 2018 and held it in 6 quarters.
- RhumbLine Advisers's Dova Pharmaceuticals position peaked at $359K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals as of Q4 2019.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.